Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Top Cited Papers
Open Access
- 18 October 2018
- journal article
- research article
- Published by Elsevier in The Lancet. Global Health
- Vol. 6 (12) , e1386-e1396
- https://doi.org/10.1016/s2214-109x(18)30346-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Risk in Vaccine Research and Development QuantifiedPLOS ONE, 2013
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Economics of New Oncology Drug DevelopmentJournal of Clinical Oncology, 2007
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006
- R&D Costs and Returns by Therapeutic CategoryDrug Information Journal, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Vaccine R&D success rates and development timesNature Biotechnology, 1996
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991